Back
Range Cancer Therapeutics ETF Stock Price Chart
2025 Gold Forecast: A Perfect Storm for Demand
Discover our Gold Price Outlook for 2025--FREE--here
Sell
30
CNCR
Range Cancer Therapeutics ETF
Last Price:
$12.35
Seasonality Move:
-4.35%
7 Day Trial
ALL ACCESS PASS
$
7
FREE REPORT: 2025 Gold Price Outlook
Get Your Copy of "2025 Gold Forecast: A Perfect Storm for Demand" Here.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CNCR is experiencing buying pressure, which is a positive indicator for future bullish movement.
Range Cancer Therapeutics ETF Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 12.66 | Sell |
| 20-day SMA: | 13.46 | Sell |
| 50-day SMA: | 14.26 | Sell |
| 200-day SMA: | 14.75 | Sell |
| 8-day EMA: | 12.65 | Sell |
| 20-day EMA: | 13.26 | Sell |
| 50-day EMA: | 13.93 | Sell |
| 200-day EMA: | 14.36 | Sell |
Range Cancer Therapeutics ETF Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.56 | Sell |
| Relative Strength Index (14 RSI): | 33.59 | Sell |
| Chaikin Money Flow: | 547 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (12.77 - 14.11) | Sell |
| Bollinger Bands (100): | (13.64 - 15.36) | Sell |
Range Cancer Therapeutics ETF Technical Analysis
| Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 20 | Dec 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 20 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Range Cancer Therapeutics ETF Stock
Is Range Cancer Therapeutics ETF Stock a Buy?
-
Range Cancer Therapeutics ETF share price is 12.35 while CNCR 8-day simple moving average is 12.66, which is a Sell signal.
-
The stock price of CNCR is 12.35 while Range Cancer Therapeutics ETF 20-day SMA is 13.46, which makes it a Sell.
-
Range Cancer Therapeutics ETF 50-day simple moving average is 14.26 while CNCR share price is 12.35, making it a Sell technically.
-
CNCR stock price is 12.35 and Range Cancer Therapeutics ETF 200-day simple moving average is 14.75, creating a Sell signal.
CNCR Technical Analysis vs Fundamental Analysis
Sell
30
Range Cancer Therapeutics ETF (CNCR)
is a Sell
Is Range Cancer Therapeutics ETF a Buy or a Sell?
-
Range Cancer Therapeutics ETF stock is rated a SellThe current Range Cancer Therapeutics ETF [CNCR] share price is $12.35. The Score for CNCR is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
Range Cancer Therapeutics ETF Stock Info
Market Cap:
0
Price in USD:
12.35
Share Volume:
547
Range Cancer Therapeutics ETF 52-Week Range
52-Week High:
17.96
52-Week Low:
11.87
Sell
30
Range Cancer Therapeutics ETF (CNCR)
is a Sell
Range Cancer Therapeutics ETF Share Price Forecast
-
What is the Range Cancer Therapeutics ETF stock price today?The Range Cancer Therapeutics ETF stock price is 12.35 USD today.
-
Will CNCR stock go up or go down?Range Cancer Therapeutics ETF> share price is forecast to RISE/FALL based on technical indicators
-
Is Range Cancer Therapeutics ETF overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Range Cancer Therapeutics ETF is overvalued.
Is Range Cancer Therapeutics ETF Stock a Buy?
-
Range Cancer Therapeutics ETF share price is 12.35 while CNCR 8-day exponential moving average is 12.65, which is a Sell signal.
-
The stock price of CNCR is 12.35 while Range Cancer Therapeutics ETF 20-day EMA is 13.26, which makes it a Sell.
-
Range Cancer Therapeutics ETF 50-day exponential moving average is 13.93 while CNCR share price is 12.35, making it a Sell technically.
-
CNCR stock price is 12.35 and Range Cancer Therapeutics ETF 200-day simple moving average is 14.36, creating a Sell signal.
Technical Analysis of Range Cancer Therapeutics ETF
Should I short Range Cancer Therapeutics ETF stock?
-
CNCR Moving Average Covergence Divergence (MACD) indicator is -0.56, suggesting Range Cancer Therapeutics ETF is a Sell
-
Range Cancer Therapeutics ETF Relative Strength Index (RSI) is 33.59, which suggest Range Cancer Therapeutics ETF is oversold
-
The Bollinger Bands (25) for Range Cancer Therapeutics ETF is (12.77 - 14.11), which suggest Range Cancer Therapeutics ETF is a Sell
-
The Bollinger Bands (100) for Range Cancer Therapeutics ETF is (13.64 - 15.36), which suggest Range Cancer Therapeutics ETF is a Sell
* Range Cancer Therapeutics ETF stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.